E.R., I couldn't agree more enthusiastically!!!! Investors have thousands of choices where to deploy their investment capital. If it weren't for several of the skilled "sleuths" that participate on this board, and others, "our" investor base would be significantly smaller than it already is. The investors that have done their DD for years, know what they have in this fantastic molecule; however, how would a potential investor find out about LL and CytoDyn? Certainly not from the "marketing" that has originated from the company. Us "old heads" can only purchase so many shares. We need some "new blood" to at least counter some of the selling as a result of our toxic financing of the past. I'm not talking NP kind of promotion, but certainly where warranted and appropriate (peer-reviewed studies, for example).